Novartis Consumer Health Canada Inc. has recalled two Excedrin products, according to a report released on January 13, 2012 by Health Canada.
The Canadian recall is part of a much larger recall of Excedrin, Bufferin, NoDoz and Gas-X Prevention products announced a week ago by Novartis Consumer Health in the USA. The Lincoln, Nebraska manufacturing plant where these products were made was the subject of a scathing inspection report issued by FDA in July 2011, and has been closed temporarily to allow for maintenance and improvements.
The Canadian recall encompasses all production lots of Excedrin Extra Strength Caplets and Excedrin Tension Headache Caplets (Expiration dates on or before December 20, 2014).
The recalled products were sold in Canada by Costco Canada and may also have been carried by other retail grocers, supermarkets and pharmacies.
For more information on the Novartis recalls, please select the Excedrin, Etc. Recalls tab.